IP Verse

Abbott Diabetes Care Inc. et al. vs DexCom, Inc.

The detailed information for PTAB case with proceeding number IPR2024-00840 filed by Abbott Diabetes Care Inc. et al. against DexCom, Inc. on May 3, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number: IPR2024-00840
Filing Date: May 3, 2024
Petitioner: Abbott Diabetes Care Inc. et al.
Respondent: DexCom, Inc.
Status: Terminated-Settled
Respondent Application Number: 13742694
Respondent Tech Center: 2600
Respondent Patent Number: 9119528
Institution Decision Date: Nov 20, 2024
Termination Date: Feb 10, 2025

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Show Exhibit Documents

Document Name	Filing Date	Category	Filing Party
Alert me when new update on this case
Termination Decision: Post-DI Settlement	Feb 10, 2025	PAPER	BOARD
Joint Motion to Terminate the Proceedings	Jan 14, 2025	PAPER	PETITIONER
Joint Request to Treat Settlement Agreement as Business Confidential	Jan 14, 2025	PAPER	PETITIONER
Ex. 1033 CONFIDENTIAL Settlement Agreement	Jan 14, 2025	EXHIBIT	PETITIONER
Patent Owner's Objections to Evidence	Dec 5, 2024	PAPER	PATENT OWNER
Institution Decision: DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314	Nov 20, 2024	PAPER	BOARD
Order: CASE MANAGEMENT AND SCHEDULING ORDER 37 C.F.R. § 42.5	Nov 20, 2024	PAPER	BOARD
Patent Owner's Preliminary Response	Aug 23, 2024	PAPER	PATENT OWNER
U.S. Patent App. Pub. No. 2009/0192380 ("Shariati")	Aug 23, 2024	EXHIBIT	PATENT OWNER
Declaration of Dr. Barry Keenan from IPR2022-00909 ("Keenan- Dec-00909")	Aug 23, 2024	EXHIBIT	PATENT OWNER
Deposition Transcript of David Rodbard, taken January 18, 2023 ("Rodbard-Dep.") IPR2022-00909	Aug 23, 2024	EXHIBIT	PATENT OWNER
Tsalikian et al., Diabetes Technol Ther. 2004 October ; 6(5): 559–566	Aug 23, 2024	EXHIBIT	PATENT OWNER
Deposition Transcript of David Rodbard, taken May 24, 2023 ("Rodbard-Reply-Dep.") IPR2022-00909	Aug 23, 2024	EXHIBIT	PATENT OWNER
Kamath et al., Journal of Diabetes Science and Technology, Vol. 4, Issue 1, January 2020 ("Kamath")	Aug 23, 2024	EXHIBIT	PATENT OWNER
U.S. Patent App. Pub. No. 2011/0193704 ("Harper")	Aug 23, 2024	EXHIBIT	PATENT OWNER
Medtronic User Guide: Guardian Real-Time Continuous Glucose Monitoring System	Aug 23, 2024	EXHIBIT	PATENT OWNER
Transcript of Deposition of Desmond Barry Keenan (March 29, 2023) in connection with IPR2022-00909	Aug 23, 2024	EXHIBIT	PATENT OWNER
Excerpt of A Dictionary of Computing, Sixth Edition, Oxford University Press (2008) ("Oxford")	Aug 23, 2024	EXHIBIT	PATENT OWNER
Petitioner's Unopposed Motion to Correct Petition	Jul 29, 2024	PAPER	PETITIONER
Notice: NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE	May 23, 2024	PAPER	BOARD
Patent Owner's Mandatory Notices	May 20, 2024	PAPER	PATENT OWNER
Power of Attorney	May 20, 2024	PAPER	PATENT OWNER
Petition : as filed	May 3, 2024	PAPER	PETITIONER
Petitioner Power of Attorney	May 3, 2024	PAPER	PETITIONER
Ex. 1001 - U.S. Patent No. 9,119,528 (528 patent)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1002 (part 1) - File History for U.S. Patent No. 9,119,528	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1002 (part 2) - File History for U.S. Patent No. 9,119,528	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1002 (part 3) - File History for U.S. Patent No. 9,119,528	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1003 - Declaration of David Rodbard MD (528 Patent)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1004 - Curriculum Vitae of David Rodbard MD	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1005 - U.S. Patent Application Publication 2007-0208244A1 (Brauker)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1006 - Guerra et al., A Dynamic Risk Measure (Aug. 2011)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1007 - Hughes et al., Hypoglycemia Prevention via Pump (Sept. 2010)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1008 - Continuous Glucose Monitoring System User’s Guide (STS Guide)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1009 - U.S. Patent No. 6,565,509 (Say)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1010 - FreeStyle Navigator Continuous Glucose... (Navigator Guide)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1011 - Sparacino, et al., Glucose Concentration Can Be Predicted (May 2	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1012 - U.S. Patent No. 10,702,215 (215 patent)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1013 - Hayter et al., Performance Standards for Continuous (2005)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1014 - Facchinetti et al., A New Index to Optimally Design (2011)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1015 - Kowalski, Can We Really Close the Loop (Sept. 2009)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1016 - U.S. Patent No. 5,973,613	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1017 - Navigator Premarket Approval P050020A	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1018 - Steil et al, Feasibility of Automating (2006)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1019 - Diabetes Care ADA 2006	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1020 - Buckingham et al., Prevention of Nocturnal Hypoglycemia (May 201	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1021 - Dassau et al., Real-Time Hypoglycemia Prediction (2010)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1022 - Kovatchev et al., Symmetrization of the Blood Glucose Measuremen	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1023 - Klonoff et al., Innovations in Technology for the Treatment (May	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1024 - U.S. Patent No. 8,160,669	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1025 - Bequette, Continuous Glucose Monitoring (Mar. 2010)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1026 - Palerm et al., Hypoglycemia Prediction and Detection Using (2005	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1027 - Declaration of Hall-Ellis	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1028 - Approved Judgment, Abbott v Dexcom, EWHC 36 (2024)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1029 - European Patent No. 2,914,159	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1030 - Scheduling Order (No. 123cv00239, D. Del. Sept. 19, 2023)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1031 - Weinzimer et al, Fully Automates Closed (2008)	May 3, 2024	EXHIBIT	PETITIONER
Ex. 1032 - Murphy et al, Closed-Loop Insulin Delivery (2011)	May 3, 2024	EXHIBIT	PETITIONER